RxDoctor Payments Data

Robert Butcher, MD

Family Medicine · Newport News, VANPI 1396735767

Payments from drug & device makers

$6,564in general payments, 2019–2025

Across 386 payments — averaging $17.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novo Nordisk$646
  • AstraZeneca$643
  • Lilly USA, LLC$574
  • Amgen$475
  • Pfizer$392
  • plus $3K from 39 others

What the payments were for

  • Food & beverage$6,547100%
  • Education$170%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,564 in reported general payments places this provider in the 90th percentile of 2,553 family medicine providers in Virginia.

See all family medicine providers in Virginia

Medicare billing

Part B allowed, 2024
$202,273
Medicare patients
336
Services billed
5,381

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide62$68,665
EliquisApixaban36$44,845
MounjaroTirzepatide24$33,658
Trelegy ElliptaFluticasone/Umeclidin/Vilanter27$25,463
JardianceEmpagliflozin16$20,992
OzempicSemaglutide22$17,536
XareltoRivaroxaban15$12,332
Advair HfaFluticasone Propion/Salmeterol11$4,758
Lantus SolostarInsulin Glargine,hum.Rec.Anlog16$3,409
Atorvastatin Calcium393$2,998
SynthroidLevothyroxine Sodium31$2,776
Levothyroxine Sodium219$2,468
Metoprolol Succinate147$2,408
Colchicine14$2,328
Rosuvastatin Calcium155$2,001

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$574$102,32386 claims
PfizerEliquis$392$44,84536 claims
GSKTrelegy Ellipta$291$25,46327 claims
Boehringer IngelheimJardiance$359$20,99216 claims
Novo NordiskOzempic$646$17,53622 claims
Johnson & JohnsonXarelto$119$12,33215 claims
AbbVieSynthroid$1,131$2,77631 claims
Almatica Pharma LLCSertraline Hcl$19$56971 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,553 family medicine providers in Virginia.

Other family medicine in Newport News

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →